2025
SJR Q1
JCR Q1 · 2,7
42 eşleşen makale
SCIE
Dergi ayrıntısı
Shock
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1073232215400514
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,827
- Quartile Q1
- H-Index 140
- Atıf/yayın 2,56
- Doküman (3y) 610
- Atıf (3y) 1.715
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 2,7
- 5Y JIF 3
- JCI 0,9
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Critical Care and Intensive Care Medicine Q2
- Emergency Medicine Q1
Alanlar
- Medicine
WoS kategorileri
- Critical Care Medicine | Hematology | Surgery | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,827 | 2,7 | 3 | 0,9 | Q1 | 140 |
| 2024 | Q1 | Q1 | 0,909 | 2,9 | 3 | 0,93 | Q1 | 137 |
| 2023 | Q1 | Q1 | 0,857 | 2,7 | 2,8 | 0,96 | Q1 | 137 |
| 2022 | Q1 | Q1 | 0,832 | 3,1 | 3,2 | 1,04 | Q1 | 137 |
| 2021 | Q1 | Q1 | 0,851 | 3,5 | 3,9 | 1,03 | Q1 | 137 |
| 2020 | Q1 | Q2 | 1,095 | 3,5 | 3,8 | 1,07 | Q1 | 137 |
| 2019 | Q1 | Q1 | 1,057 | 3 | 3,3 | 1,07 | Q1 | 137 |
| 2018 | — | Q1 | — | 3,1 | 3,2 | 1,05 | Q1 | — |
| 2017 | Q1 | Q1 | 1,331 | 3 | 3,2 | 1,1 | Q1 | 137 |
| 2016 | Q1 | Q1 | 1,331 | 3,1 | 2,9 | — | — | 137 |
| 2015 | Q1 | Q1 | 1,45 | 3 | 2,8 | — | — | 137 |
| 2014 | Q1 | Q1 | 1,303 | 3 | 2,8 | — | — | 137 |
| 2013 | Q1 | Q1 | 1,373 | 2,7 | 2,8 | — | — | 137 |
| 2012 | Q1 | Q1 | 1,27 | 2,6 | 2,8 | — | — | 137 |
| 2011 | Q1 | Q1 | 1,168 | 2,8 | 3 | — | — | 137 |
| 2010 | Q1 | Q1 | 1,476 | 3,2 | 3,4 | — | — | 137 |
| 2009 | — | Q1 | — | 2,9 | 3,3 | — | — | — |
| 2008 | — | Q1 | — | 3,4 | 3,2 | — | — | — |
| 2007 | — | Q1 | — | 3,3 | 3,2 | — | — | — |
| 2006 | — | Q1 | — | 3,3 | — | — | — | — |
| 2005 | — | Q1 | — | 3,1 | — | — | — | — |
| 2004 | — | Q1 | — | 3,1 | — | — | — | — |
| 2003 | — | Q1 | — | 2,5 | — | — | — | — |
| 2002 | — | Q1 | — | 2,5 | — | — | — | — |
| 2001 | — | Q1 | — | 2,2 | — | — | — | — |
| 2000 | — | Q1 | — | 2,8 | — | — | — | — |
| 1999 | — | Q1 | — | 2,8 | — | — | — | — |
| 1998 | — | Q1 | — | 2,6 | — | — | — | — |
| 1997 | — | Q1 | — | 2,4 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 30/66 |
| 2025 | HEMATOLOGY | SCIE | Q2 | Q1 | 46/103 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 48/100 |
| 2025 | SURGERY | SCIE | Q1 | Q2 | 73/321 |
| 2024 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 21/62 |
| 2024 | HEMATOLOGY | SCIE | Q2 | Q1 | 34/99 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 34/98 |
| 2024 | SURGERY | SCIE | Q1 | Q2 | 54/314 |
| 2023 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 22/55 |
| 2023 | HEMATOLOGY | SCIE | Q2 | Q1 | 35/97 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 34/96 |
| 2023 | SURGERY | SCIE | Q1 | Q2 | 56/292 |
| 2022 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q1 | 21/35 |
| 2022 | HEMATOLOGY | SCIE | Q3 | Q1 | 42/79 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 31/68 |
| 2022 | SURGERY | SCIE | Q1 | Q1 | 50/213 |
| 2021 | CRITICAL CARE MEDICINE | SCIE | Q3 | Q2 | 18/35 |
| 2021 | HEMATOLOGY | SCIE | Q3 | Q1 | 44/78 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 33/67 |
| 2021 | SURGERY | SCIE | Q1 | Q1 | 53/213 |
| 2020 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q1 | 17/36 |
| 2020 | HEMATOLOGY | SCIE | Q2 | Q1 | 36/76 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 30/65 |
| 2020 | SURGERY | SCIE | Q2 | Q1 | 59/211 |
| 2019 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q1 | 15/36 |
| 2019 | HEMATOLOGY | SCIE | Q2 | Q1 | 34/76 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 24/65 |
| 2019 | SURGERY | SCIE | Q1 | Q1 | 51/210 |
| 2018 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 11/33 |
| 2018 | HEMATOLOGY | SCIE | Q2 | Q1 | 33/73 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 23/65 |
| 2018 | SURGERY | SCIE | Q1 | Q1 | 43/203 |
| 2017 | CRITICAL CARE MEDICINE | SCIE | Q2 | Q2 | 15/33 |
| 2017 | HEMATOLOGY | SCIE | Q2 | Q1 | 27/71 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 26/65 |
| 2017 | SURGERY | SCIE | Q1 | Q1 | 42/200 |
| 2016 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 13/33 |
| 2016 | HEMATOLOGY | SCIE | Q2 | — | 29/70 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 26/63 |
| 2016 | SURGERY | SCIE | Q1 | — | 40/197 |
| 2015 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 12/33 |
| 2015 | HEMATOLOGY | SCIE | Q2 | — | 29/70 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/63 |
| 2015 | SURGERY | SCIE | Q1 | — | 33/200 |
| 2014 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 9/27 |
| 2014 | HEMATOLOGY | SCIE | Q2 | — | 26/68 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/60 |
| 2014 | SURGERY | SCIE | Q1 | — | 32/198 |
| 2013 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 11/27 |
| 2013 | HEMATOLOGY | SCIE | Q2 | — | 27/68 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 29/65 |
| 2013 | SURGERY | SCIE | Q1 | — | 39/204 |
| 2012 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 12/27 |
| 2012 | HEMATOLOGY | SCIE | Q2 | — | 33/67 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 32/68 |
| 2012 | SURGERY | SCIE | Q1 | — | 36/199 |
| 2011 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 9/26 |
| 2011 | HEMATOLOGY | SCIE | Q2 | — | 30/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/68 |
| 2011 | SURGERY | SCIE | Q1 | — | 30/199 |
| 2010 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 7/23 |
| 2010 | HEMATOLOGY | SCIE | Q2 | — | 25/66 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 16/68 |
| 2010 | SURGERY | SCIE | Q1 | — | 20/188 |
| 2009 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 6/22 |
| 2009 | HEMATOLOGY | SCIE | Q2 | — | 26/61 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/61 |
| 2009 | SURGERY | SCIE | Q1 | — | 23/167 |
| 2008 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 6/21 |
| 2008 | HEMATOLOGY | SCIE | Q2 | — | 22/62 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/56 |
| 2008 | SURGERY | SCIE | Q1 | — | 15/148 |
| 2007 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 6/19 |
| 2007 | HEMATOLOGY | SCIE | Q2 | — | 20/63 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 15/54 |
| 2007 | SURGERY | SCIE | Q1 | — | 12/139 |
| 2006 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 5/18 |
| 2006 | HEMATOLOGY | SCIE | Q2 | — | 18/61 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 14/52 |
| 2006 | SURGERY | SCIE | Q1 | — | 12/137 |
| 2005 | CRITICAL CARE MEDICINE | SCIE | Q1 | — | 4/18 |
| 2005 | HEMATOLOGY | SCIE | Q2 | — | 20/60 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/51 |
| 2005 | SURGERY | SCIE | Q1 | — | 13/139 |
| 2004 | CRITICAL CARE MEDICINE | SCIE | Q1 | — | 4/17 |
| 2004 | HEMATOLOGY | SCIE | Q2 | — | 20/62 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/51 |
| 2004 | SURGERY | SCIE | Q1 | — | 11/139 |
| 2003 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 5/16 |
| 2003 | HEMATOLOGY | SCIE | Q2 | — | 20/62 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/52 |
| 2003 | SURGERY | SCIE | Q1 | — | 16/141 |
| 2002 | CRITICAL CARE MEDICINE | SCIE | Q1 | — | 4/17 |
| 2002 | HEMATOLOGY | SCIE | Q2 | — | 19/61 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/52 |
| 2002 | SURGERY | SCIE | Q1 | — | 17/141 |
| 2001 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 5/17 |
| 2001 | HEMATOLOGY | SCIE | Q2 | — | 19/59 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/50 |
| 2001 | SURGERY | SCIE | Q1 | — | 19/139 |
| 2000 | CRITICAL CARE MEDICINE | SCIE | Q2 | — | 4/15 |
| 2000 | HEMATOLOGY | SCIE | Q1 | — | 15/60 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 14/45 |
| 2000 | SURGERY | SCIE | Q1 | — | 13/136 |
| 1999 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q1 | — | 4/23 |
| 1999 | HEMATOLOGY | SCIE | Q1 | — | 14/60 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 13/44 |
| 1999 | SURGERY | SCIE | Q1 | — | 9/131 |
| 1998 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q1 | — | 4/21 |
| 1998 | HEMATOLOGY | SCIE | Q2 | — | 15/59 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 13/39 |
| 1998 | SURGERY | SCIE | Q1 | — | 9/128 |
| 1997 | EMERGENCY MEDICINE & CRITICAL CARE | SCIE | Q1 | — | 4/20 |
| 1997 | HEMATOLOGY | SCIE | Q1 | — | 14/59 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 13/38 |
| 1997 | SURGERY | SCIE | Q1 | — | 9/114 |